Breaking News
January 19, 2018 - ‘You’re Old and You Need Tests’: What We Heard This Week
January 19, 2018 - Egg-preserving hysterectomy raises heart risks later: study
January 19, 2018 - GA-map Dysbiosis Test identifies IBS patients who respond to FODMAP diet, study shows
January 19, 2018 - Study explores mortality and health-related habits in former elite athletes and their brothers
January 19, 2018 - New biodegradable sensors could assist doctors
January 19, 2018 - Modular gene enhancers may be suitable target in treatment of blood cancer
January 18, 2018 - New precision medicine trial for metastatic pancreatic cancer
January 18, 2018 - Shire Receives FDA Breakthrough Therapy Designation for Maribavir, an Investigational Treatment for Cytomegalovirus (CMV) Infection in Transplant Patients
January 18, 2018 - Pre-Existing Patient-Valve Mismatch Trips Up ViV Implant
January 18, 2018 - Adolescents: health risks and solutions
January 18, 2018 - US woman delivers baby from embryo frozen for 24 years
January 18, 2018 - Study identifies new target for treatment of depression
January 18, 2018 - LJI study reveals key player that promotes skin inflammation in atopic dermatitis
January 18, 2018 - Study devises efficient and economical strategy to screen breast and ovarian cancer gene mutations
January 18, 2018 - Agile Therapeutics, Inc. Receives a Complete Response Letter from the FDA for Twirla (AG200-15) for the Prevention of Pregnancy
January 18, 2018 - Gene Therapy for Inherited Retinal Dystrophy Gets FDA Clearance
January 18, 2018 - Researchers identify a new chemical pathway that helps the brain detect sweet, savory and bitter flavors
January 18, 2018 - IBV develops platform that helps companies to diagnose wellbeing of their workforce
January 18, 2018 - Study to test new precision medicine approach for metastatic pancreatic cancer
January 18, 2018 - World’s first vaccine relieves grass pollen allergy symptoms by at least 25%, study shows
January 18, 2018 - FDA Approves New Indication for Gilotrif (afatinib) in EGFR Mutation-Positive NSCLC
January 18, 2018 - Oncologists Dish on Top Issues for 2018
January 18, 2018 - Researchers identify new potential drug target for Huntington’s disease
January 18, 2018 - Metrohm USA welcomes employees to new headquarters in Florida
January 18, 2018 - Human waste remains main source of fecal pollution in the river Danube
January 18, 2018 - Expert discusses how to stay healthy during flu season
January 18, 2018 - New biomaterials-based system improves T-cell production
January 18, 2018 - Novel gene expression analysis technique can accurately and quickly measure RNA
January 18, 2018 - Grandparents Help Shape Kids’ Views on Aging
January 18, 2018 - Absolutely Zero Stent Thrombosis at 5 Years With Bioabsorbable MiStent
January 18, 2018 - Safe Sleep for Babies | VitalSigns
January 18, 2018 - Pfizer to launch own little white pill
January 18, 2018 - Aged garlic extract may help obese people fight against inflammation, study shows
January 18, 2018 - Sex steroid hormone fluctuations may have direct effects on eye physiology and AMD
January 18, 2018 - Patients with monoclonal gammopathy at risk of developing cancer even after 30 years
January 18, 2018 - Researchers reveal potential of multivalent antibodies for HIV prevention, treatment and cure
January 18, 2018 - Dying cancer patients receiving assisted hydration live longer
January 18, 2018 - Potential male birth control pill could be developed from arrow poison
January 18, 2018 - Research reveals cost-effectiveness of whole-population screening for breast, ovarian cancer gene mutations
January 18, 2018 - Genes involved in spinal cord repair of lamprey also present in mammals, study reveals
January 18, 2018 - Researchers unravel key molecular mechanism of autoimmune and inflammatory diseases
January 18, 2018 - The State of the Drug Discovery Nation Unveiled as New Report Provides Vital Insights for the Development of New Medicines
January 18, 2018 - Dutch Study Links Implants to Increased Breast-ALCL Risk
January 18, 2018 - Five addiction experts weigh in on future of opioid crisis. Their forecast: grim
January 18, 2018 - EXD2 enzyme facilitates protein production in mitochondria
January 18, 2018 - Kessler Foundation wins $735,000 grant for training rehabilitation researchers
January 18, 2018 - Researchers find new way to halt growth of breast cancer cells
January 18, 2018 - Cantex Pharmaceuticals, Inc. Announces FDA Orphan Drug Designation Has Been Granted to CX-01 for Treatment of Acute Myeloid Leukemia
January 18, 2018 - Civilians Now Getting Flu-Like Illness Afflicting Troops
January 18, 2018 - Discovery brings stem cell therapy for eye disease closer to the clinic
January 18, 2018 - Guts of surfers more likely to be colonized by antibiotic-resistant bacteria, study reveals
January 18, 2018 - Bacteria linked to periodontitis may play role in onset of cancer
January 18, 2018 - Jazz Pharmaceuticals Submits New Drug Application for Solriamfetol (JZP-110) for Excessive Sleepiness Associated with Narcolepsy and Obstructive Sleep Apnea
January 18, 2018 - Early Menarche, Menopause Tied to Higher CVD Risk
January 18, 2018 - Pioneering new technique could boost understanding of causes of heart disease
January 18, 2018 - New brain imaging techniques show how infants’ brains process ‘touch’
January 18, 2018 - GSK Receives FDA Approval for Expanded Indication for Fluarix Quadrivalent (Influenza Vaccine) for Persons 6 Months and Older
January 18, 2018 - Blood Markers Point to Maladaptive LV Remodeling
January 18, 2018 - Effect of gut bacteria on specific immune cells underlies persistent liver inflammation
January 18, 2018 - Study reveals new diabetes gene in families with rare blood sugar conditions
January 18, 2018 - Fewer Hospitals Closed After Obamacare Expanded Medicaid
January 18, 2018 - At-Home Breath Training Improves Asthma Quality of Life
January 18, 2018 - Obesity can add five weeks of asthma symptoms per year in preschoolers
January 18, 2018 - Neuronal loss is very limited in Alzheimer’s disease, shows new study
January 18, 2018 - A new strategy proposed for drug discovery
January 17, 2018 - Lactation May Lower T2D Risk in Younger Women
January 17, 2018 - New Atopic Dermatitis Yardstick provides practical guidance and management insights
January 17, 2018 - New biodegradable pressure sensor could help monitor serious health conditions
January 17, 2018 - HSS orders Sectra’s 3D pre-operative planning solution for improving patient outcomes
January 17, 2018 - Study identifies six new genes regions associated with diabetes
January 17, 2018 - Women do not receive timely diagnosis for heart disease
January 17, 2018 - AbbVie’s Upadacitinib Shows Positive Results as Monotherapy in Phase 3 Rheumatoid Arthritis Study, Meeting All Primary and Key Secondary Endpoints
January 17, 2018 - Should President Trump’s Physical Include a Cognitive Screen?
January 17, 2018 - Could gene therapy someday eliminate HIV?
January 17, 2018 - Researchers identify new anti-inflammatory drug target
January 17, 2018 - Loxo Oncology Initiates Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Larotrectinib for the Treatment of TRK Fusion Cancers
January 17, 2018 - Trunk Imaging Tied to Higher Nephrectomy Risk
January 17, 2018 - Campaigners incensed at failings in Africa AIDS war
January 17, 2018 - Research opens door to development of new treatment for type 2 diabetes
January 17, 2018 - Uniqsis’ novel reactor system for continuous flow synthesis
New oxytocin chemical sensor could be first step towards early diagnosis of autism

New oxytocin chemical sensor could be first step towards early diagnosis of autism

image_pdfDownload PDFimage_print

Is it going to be possible to detect features of autism at birth? At the Institute of Physical Chemistry of the Polish Academy of Sciences in Warsaw a sensor has come into being that means this may become a reality. The main recognition component of the new device is a polymer layer with a carefully designed structure. It recognizes molecules of oxytocin, a compound considered to be one of the biomarkers of autism.

Molecules of many different chemical compounds circulate in human blood. One of them is oxytocin, a compound more commonly known as the ‘love hormone’. Distinct changes in its blood concentration suggest the patient may potentially be predisposed to autism. It will be possible to detect these changes using a new chemical sensor, designed and fabricated at the Institute of Physical Chemistry of the Polish Academy of Sciences (IPC PAS) in Warsaw, which selectively recognizes even small amounts of oxytocin. A description of work on the device, funded by the Iuventus Plus grant from the Ministry of Science and Higher Education of Poland, has just been published in Biosensors and Bioelectronics, a scientific journal of high reputation.

In medicine, there are occasional breakthroughs that result in a qualitative improvement in the health of entire populations. In the 20th century, such moments include the discovery of antibiotics or the spread of vaccination. Today, it seems that in the near future a revolution on a similar scale will come about thanks to new diagnostic devices that are sensitive, accurate, fast, and above all small and very cheap. Available at all times and to everybody – perhaps even wearable or incorporated in everyday items? – these instruments could detect diseases at very early stages of development, thereby contributing to a dramatic increase in treatment efficacy. The key element of this type of innovative diagnostic instrument must be reliable sensors capable of reacting to the presence of even a small number of molecules of highly discriminative with respect to selected chemical compounds.

“In the devices developed in our research team, the role of recognizing the sought after compounds is played by carefully fabricated and equally carefully produced polymer layers. The main idea here is simple, i.e., for each compound to be recognized we try to build a layer of a polymer with cavities – molecular voids – that are as best as possible suited to the shape as well as physical and chemical properties of the molecules of the chemical compound that we want to recognize in the sensor’s surroundings,” says Prof. Wlodzimierz Kutner (IPC PAS).

‘Stamping’ the shape and properties of molecules of the selected compound in the polymer matrix is a technique known as molecular imprinting. Functional monomers are introduced into a solution containing the molecules that are to be detected. They attach to characteristic binding sites on the molecules to be imprinted. A cross-linking monomer is then introduced which rapidly binds to the functional monomers. The target recognition layer is formed after polymerization of the cross-linking monomer, and then rinsing out from the structure thus formed the molecules of the compound selected for detection.

Prof. Kutner’s team has already developed many polymer layers that selectively react to even low concentrations of important chemicals, including melamine, nicotine, albumin and neopterin (one of the biomarkers of cancer). Oxytocin has just joined this group.

“It’s one thing to capture oxytocin molecules in a polymer layer, but quite another to read the information that the molecular cavities have been filled,” notes Dr. Zofia Iskierko from Prof. Kutner’s team and explains: “For us, the signal of the presence of oxytocin in the recognition layer is a change in electrical capacitance. That is why we produce these layers on small gold electrodes. We insert the electrodes into a tube through which a solution of blood (in our tests artificial blood) flows. The oxytocin molecules sink into the cavities of the polymer layer, thus changing the electrical capacitance of the measuring system.”

In experimental tests, it turned out that the new sensor detects micromolar concentrations of oxytocin and reacts to its presence even when it is surrounded by molecules of a very similar structure. Professor Kutner’s team is working on increasing the sensitivity of the sensor to a level that allows detection of nanomolar concentrations. The aim here is to achieve a sensitivity that allows a single, small drop of blood to be used to carry out a variety of diagnostic tests. The experiments performed at the IPC PAS labs also showed that the polymer recognition layer is relatively durable and allows multiple measurement repetitions without detriment to their sensitivity and selectivity.

Changes in blood oxytocin concentration alone do not make it clear whether a person is predisposed to autism. Before the diagnosis is made, the concentration of at least a few other substances (biomarkers) characteristically associated with this disease should be checked.

“Our oxytocin chemical sensor is really only a first step towards building a more advanced medical device that diagnoses a predisposition to autism. For some time, we have been working on polymer layers that respond to the presence of two other compounds associated with autism, namely, melatonin (which should not be confused with melamine) and gamma-aminobutyric acid,” stresses the leader of the research project Dr. Piyush S. Sharma (IPC PAS).

Tagged with:

About author

Related Articles